Skip to main content

Table 3 GRADE evidence profiles for primary outcomes among the trials included in the systematic review

From: Inducing labor after fetal demise: a systematic review and meta-analysis of the efficacy and safety of mifepristone and misoprostol combination versus misoprostol alone

Certainty assessment

№ of patients

Effect

Certainty

Importance

№ of studies

Study design

Risk of bias

Inconsistency

Indirectness

Imprecision

Other considerations

[mifepristone and misoprostol]

[misoprostol]

Relative

(95% CI)

Absolute

(95% CI)

Induction delivery interval

10

randomised trials

seriousa

not seriousb

not serious

not serious

publication bias strongly suspectedc

356

354

-

MD 7.86 lower

(9.98 lower to 5.73 lower)

Lowa,b,c

CRITICAL

Number of misoprostol doses

9

randomised trials

seriousa

not seriousb

not serious

not serious

none

315

316

-

MD 1.38 lower

(1.82 lower to 0.94 lower)

Moderatea,b

CRITICAL

Total dose of misoprostol

4

randomised trials

seriousa

not seriousb

not serious

seriousd

none

165

172

-

MD 60.51 lower

(106.98 lower to 14.04 lower)

Lowa,b,d

CRITICAL

  1. CIConfidence interval; MD Mean difference
  2. Explanations
  3. aThe overall bias is high in most studies
  4. bAlthough heterogeneity is high, the heterogeneity is caused by differences in the magnitude of effectiveness rather than by effectiveness and ineffectiveness
  5. cThe funnel plot is not symmetrical
  6. dThe total sample size is less than 400